Cost-utility analysis of pralatrexate for relapsed or refractory peripheral T-cell lymphoma based on a case-matched historical control study along with single arm clinical trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Works matching AU Baik, Deborah
Results: 3
1
2
Cost‐utility analysis of emicizumab prophylaxis in haemophilia A patients with factor VIII inhibitors in Korea.
- Published in:
- Haemophilia, 2021, v. 27, n. 1, p. e12, doi. 10.1111/hae.14143
- By:
- Publication type:
- Article
3
Prevalence and patterns of the concurrent use of anticholinergics for the motor symptoms of Parkinson's disease and acetylcholinesterase inhibitors in Parkinson's disease patients with dementia: a cross-sectional study using Korea National Health Insurance claims data.
- Published in:
- 2022
- By:
- Publication type:
- journal article